Terms: = Leukemia AND TBL1XR1, C21, 79718, TBLR1, IRA1, FLJ12894, DC42
42 results:
1. Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children-A Single Center Experience.
Borkovskaia A; Bogacheva S; Konyukhova T; Dadakhanova E; Gaskova M; Soldatkina O; Dubrovina M; Popov A; Mikhailova E; Inushkina E; Kazanov M; Matveev E; Novichkova G; Maschan M; Maschan A; Olshanskaya Y; Zerkalenkova E
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980947
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations.
Mochida K; Nakahata S; Suzuki Y; Inoue K; Moriguchi S; Yamashita A; Amano M; Morishita K
J Dermatol Sci; 2023 Feb; 109(2):80-88. PubMed ID: 36842846
[TBL] [Abstract] [Full Text] [Related]
3. In Vitro Study of Cytotoxic Mechanisms of Alkylphospholipids and Alkyltriazoles in Acute Lymphoblastic leukemia Models.
Jesus LOP; de Souza AA; Torquato HFV; Gontijo VS; Pereira de Freitas R; Gesteira TF; Coulson-Thomas VJ; Torquato RJS; Tanaka AS; Paredes-Gamero EJ; Judice WAS
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500726
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
5. Identification of the global miR-130a targetome reveals a role for tbl1xr1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Krivdova G; Voisin V; Schoof EM; Marhon SA; Murison A; McLeod JL; Gabra MM; Zeng AGX; Aigner S; Yee BA; Shishkin AA; Van Nostrand EL; Hermans KG; Trotman-Grant AC; Mbong N; Kennedy JA; Gan OI; Wagenblast E; De Carvalho DD; Salmena L; Minden MD; Bader GD; Yeo GW; Dick JE; Lechman ER
Cell Rep; 2022 Mar; 38(10):110481. PubMed ID: 35263585
[TBL] [Abstract] [Full Text] [Related]
6. Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact.
Krzisch D; Guedes N; Boccon-Gibod C; Baron M; Bravetti C; Davi F; Armand M; Smagghe L; Caron J; Bernard OA; Susin S; Chapiro E; Leblond V; Nguyen-Khac F; Roos-Weil D;
Am J Hematol; 2021 Dec; 96(12):1569-1579. PubMed ID: 34462944
[TBL] [Abstract] [Full Text] [Related]
7. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
[TBL] [Abstract] [Full Text] [Related]
8. A novel fusion protein tblr1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies.
Li S; Yang X; Liu S; Chen Y; Xing H; Tang K; Tian Z; Xu Y; Rao Q; Wang M; Wang J
Cell Death Dis; 2021 Jun; 12(6):607. PubMed ID: 34117212
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis.
Galatà G; García-Montero AC; Kristensen T; Dawoud AAZ; Muñoz-González JI; Meggendorfer M; Guglielmelli P; Hoade Y; Alvarez-Twose I; Gieger C; Strauch K; Ferrucci L; Tanaka T; Bandinelli S; Schnurr TM; Haferlach T; Broesby-Olsen S; Vestergaard H; Møller MB; Bindslev-Jensen C; Vannucchi AM; Orfao A; Radia D; Reiter A; Chase AJ; Cross NCP; Tapper WJ
Am J Hum Genet; 2021 Feb; 108(2):284-294. PubMed ID: 33421400
[TBL] [Abstract] [Full Text] [Related]
10. Genotypic and Phenotypic Characteristics of Acute Promyelocytic leukemia Translocation Variants.
Mannan A; Muhsen IN; Barragán E; Sanz MA; Mohty M; Hashmi SK; Aljurf M
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):189-201. PubMed ID: 32473106
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
[TBL] [Abstract] [Full Text] [Related]
12. Acute promyelocytic leukemia with a cryptic insertion of RARA into tbl1xr1.
Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
[TBL] [Abstract] [Full Text] [Related]
13. BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells.
Yang J; Chen L; Yan Y; Qiu J; Chen J; Song J; Rao Q; Ben-David Y; Li Y; Hao X
Biomed Pharmacother; 2019 Apr; 112():108603. PubMed ID: 30784914
[TBL] [Abstract] [Full Text] [Related]
14. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
[TBL] [Abstract] [Full Text] [Related]
15. Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.
Bezzerri V; Cipolli M
Mol Diagn Ther; 2019 Apr; 23(2):281-290. PubMed ID: 30413969
[TBL] [Abstract] [Full Text] [Related]
16. Two new C
Zhao D; Su SS; Chen SF; Lu XJ; Chen G; Wang YB; Su GY; Pei YH
Chin J Nat Med; 2018 Aug; 16(8):610-614. PubMed ID: 30197126
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract] [Full Text] [Related]
18. Integrated molecular profiling of juvenile myelomonocytic leukemia.
Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
[TBL] [Abstract] [Full Text] [Related]
19. Structure determination of two new C
Zhao D; Tang MX; Su SS; Lu XJ; Wang YB; Chen SF; Wang HF; Chen G; Pei YH
J Asian Nat Prod Res; 2018 Sep; 20(9):852-859. PubMed ID: 29099237
[TBL] [Abstract] [Full Text] [Related]
20. Dexamethasone-(c21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).
Coyne CP; Narayanan L
Drug Des Devel Ther; 2016; 10():2575-97. PubMed ID: 27574398
[TBL] [Abstract] [Full Text] [Related]
[Next]
